FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.21  |  FHIR Version n/a  User: [n/a]

37058011000001109: Dihydrocodeine 30mg tablets (Mawdsley-Brooks & Company Ltd) (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 15-May 2019. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
169101000001116 Dihydrocodeine 30mg tablets (Mawdsley-Brooks & Company Ltd) en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
169121000001111 Dihydrocodeine 30mg tablets (Mawdsley-Brooks & Company Ltd) (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Dihydrocodeine 30mg tablets (Mawdsley-Brooks & Company Ltd) Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Dihydrocodeine 30mg tablets (Mawdsley-Brooks & Company Ltd) Is a Product containing precisely dihydrocodeine 30 milligram/1 each conventional release oral tablet false Inferred relationship Existential restriction modifier
Dihydrocodeine 30mg tablets (Mawdsley-Brooks & Company Ltd) Is a Actual medicinal product true Inferred relationship Existential restriction modifier
Dihydrocodeine 30mg tablets (Mawdsley-Brooks & Company Ltd) Has specific active ingredient Dihydrocodeine tartrate true Inferred relationship Existential restriction modifier
Dihydrocodeine 30mg tablets (Mawdsley-Brooks & Company Ltd) Has dispensed dose form Tablet true Inferred relationship Existential restriction modifier
Dihydrocodeine 30mg tablets (Mawdsley-Brooks & Company Ltd) VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Dihydrocodeine 30mg tablets (Mawdsley-Brooks & Company Ltd) Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category Schedule 5 (CD Inv) true Inferred relationship Existential restriction modifier
Dihydrocodeine 30mg tablets (Mawdsley-Brooks & Company Ltd) VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Dihydrocodeine 30mg tablets (Mawdsley-Brooks & Company Ltd) Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction none true Inferred relationship Existential restriction modifier
Dihydrocodeine 30mg tablets (Mawdsley-Brooks & Company Ltd) Is a Dihydrocodeine 30mg tablets true Inferred relationship Existential restriction modifier
Dihydrocodeine 30mg tablets (Mawdsley-Brooks & Company Ltd) Is a Dihydrocodeine 30mg tablets false Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Dihydrocodeine 30mg tablets (Mawdsley-Brooks & Company Ltd) 30 tablet Has AMP True Dihydrocodeine 30mg tablets (Mawdsley-Brooks & Company Ltd) Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start